The diabetes therapeutic biguanides metformin and its more potent analog, phenformin, inhibit mitochondrial respiratory chain complex I and ATP synthesis, thus resulting in energy stress and indirectly activating AMPK [40,41,42]. The gene discussed is PRKAA1; the disease is diabetes mellitus.